Patient-derived organoids as a predictive biomarker for treatment response in cancer patients

Effective predictive biomarkers are needed to enable personalized medicine and increase treatment efficacy and survival for cancer patients, thereby reducing toxic side effects and treatment costs. Patient-derived organoids (PDOs) enable individualized tumour response testing. Since 2018, 17 publica...

Descripción completa

Detalles Bibliográficos
Autores principales: Wensink, G. Emerens, Elias, Sjoerd G., Mullenders, Jasper, Koopman, Miriam, Boj, Sylvia F., Kranenburg, Onno W., Roodhart, Jeanine M. L.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2021
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8042051/
https://www.ncbi.nlm.nih.gov/pubmed/33846504
http://dx.doi.org/10.1038/s41698-021-00168-1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8042051/
https://www.ncbi.nlm.nih.gov/pubmed/33846504
http://dx.doi.org/10.1038/s41698-021-00168-1

Ejemplares similares